AmeriCann, Inc. designs, develops, leases, and operates cannabis cultivation, processing, and manufacturing facilities in the United States. The company engages in the product manufacturing and greenhouse cultivation facilities for licensed cannabis business. Its flagship project is the Massachusetts Cannabis Center that is developed on a 52-acre parcel of land located in Freetown, southeastern Massachusetts. The company also provides medical cannabis and adult-use cannabis. The company was formerly known as Nevada Health Scan, Inc. and changed its name to AmeriCann, Inc. in 2014. AmeriCann, Inc. was incorporated in 2010 and is headquartered in Denver, Colorado.
Stock data | 2023 | Change |
---|---|---|
Price | $0.028 | N/A |
Market Cap | $682.97K | N/A |
Shares Outstanding | 24.39M | 0.24% |
Employees | 3.00 | N/A |
Shareholder Equity | 5.71M | -1.63% |
Valuation | 2023 | Change |
---|---|---|
P/E Ratio | -7.21 | N/A |
P/S Ratio | 0.27 | N/A |
P/B Ratio | 0.12 | N/A |
Growth | 2023 | Change |
---|---|---|
Return on Equity | -0.0166 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $2.55M | N/A |
Earnings | -$94.75K | N/A |
EPS | -0.0039 | N/A |
Earnings Yield | -0.1387 | N/A |
Gross Margin | 0.9937 | N/A |
Operating Margin | 0.2397 | N/A |
Net income margin | -0.0371 | N/A |
Financial Strength | 2023 | Change |
---|---|---|
Total Assets | $15.15M | N/A |
Total Debt | $9.30M | N/A |
Cash on Hand | $1.14M | N/A |
Debt to Equity | $1.66 | -0.32% |
Cash to Debt | 0.1221 | -15.38% |
Current Ratio | 0.2544 | -92.56% |